PNW PEPTIDES
Tesamorelin laboratory vial

TSM-041

Tesamorelin

$78.00

Lyophilized Tesamorelin peptide, supplied in 10mg and 20mg vial sizes, HPLC-verified purity with mass spectrometry identity confirmation. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered with a modified N-terminus for enhanced stability in

1
View cart

In stock · 10mg / vial · ships in 1–2 business days

Purity
≥ 99% (HPLC)
Quantity
10mg / vial
Form
Lyophilized powder
Molecular weight
Stock status
In stock
Source
krause analytical
Lot / batch
Lot 1 · COA issued 2026-08-10

Certificate of Analysis

Tesamorelin COA · August 2026

Storage information

Store lyophilized material at -20 °C, protected from light and moisture. Once reconstituted for laboratory work, keep at 2–8 °C and avoid repeated freeze-thaw cycles.

Shipping

Insulated packaging with tracked domestic and international delivery. Import eligibility is the purchaser's responsibility.

Research Use Only

Intended solely for laboratory and in-vitro research by qualified professionals. Not approved for human consumption, veterinary use, or the diagnosis, treatment, cure, or prevention of any disease. Not a drug, supplement, food, or cosmetic.

Product description

Lyophilized Tesamorelin peptide, supplied in 10mg and 20mg vial sizes, HPLC-verified purity with mass spectrometry identity confirmation. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered with a modified N-terminus for enhanced stability in laboratory applications compared to native GHRH.

In research settings, tesamorelin is studied for its role in growth hormone signaling pathways, specifically its interaction with GHRH receptors and downstream effects on the GH/IGF-1 axis. Researchers investigating endocrine regulation, body composition, and metabolic research models use this compound to better understand growth hormone secretagogue mechanisms. Its relevance extends to research on visceral fat metabolism and lipid regulation pathways within laboratory models.

Each vial is supplied in lyophilized (freeze-dried) powder form to preserve peptide stability during shipping and storage. After reconstitution with an appropriate diluent, solutions should be stored refrigerated and used according to your laboratory's standard handling protocols. See our Reconstitution Guide for detailed instructions.

This product is supplied strictly for laboratory research use only (RUO). It is not a drug, dietary supplement, or cosmetic, and is not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. Purchasers must be qualified researchers, laboratories, or institutions acquiring this product for legitimate scientific research purposes only, in full accordance with our Terms of Service and RUO Disclaimer.

Further reading: See our Tesamorelin research overview for a detailed breakdown of the mechanism and clinical trial data, or see how it compares to other compounds in our growth hormone secretagogues overview.

Certificate of analysis

Testing laboratory Krause Analytical LLC, Austin, TX
Lab reference 210665
Chromatographic purity >99.9%
Quantity vs. label 9.10 mg (91.0% of 10 mg claim)
Mass spectral match ID confirmed
Method HPLC-UV/MS
Analysis date 6 August 2026
CAS 218949-48-5

View full certificate and chromatogram · Verify with Krause Analytical

Tesamorelin reference information

Vial and presentation

Each Tesamorelin vial is supplied as lyophilized powder at 10mg / vial, sealed and labelled with catalogue code TSM-041. Vials are inspected before release and shipped in insulated packaging.

Purity and testing

Identity and purity are confirmed by third-party HPLC and mass spectrometry, with the result stated as ≥ 99% (HPLC). The full Certificate of Analysis for this lot is viewable on this page.

Storage

Store lyophilized material at -20 °C, protected from light and moisture. Once reconstituted for laboratory work, keep at 2–8 °C and avoid repeated freeze-thaw cycles.

Reconstitution

Reconstitution for laboratory work is performed with bacteriostatic water or another suitable diluent, added slowly against the vial wall and swirled rather than shaken. Record the volume used so concentrations remain traceable. Supplied for research use only; not for human or veterinary use.

Other reference materials

Glp-3 (rt) laboratory vial

CDA-RT101

Glp-3 (rt)

Purity
≥ 99% (HPLC)
Quantity
600 mg / vial
Ghku laboratory vial

CDA-GHK201

Ghku

Purity
≥ 98% (HPLC)
Quantity
100 mg / vial
Nad+ laboratory vial

CDA-NAD315

Nad+

Purity
≥ 99% (HPLC)
Quantity
500 mg / vial
Bpc-157 laboratory vial

CDA-BPC157

Bpc-157

Purity
≥ 98% (HPLC)
Quantity
10 mg / vial